Q1 FY27 Results Approved, MD Re-appointed for 5 Years
DOLPHIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 5.5 pts less than its Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 unaudited results for quarter ended June 30, 2026. Standalone revenue from operations rose to Rs 246.33 lakhs (vs Rs 40 lakhs YoY), but PAT fell to Rs 91.08 lakhs (vs Rs 124.08 lakhs) on higher finance costs. Consolidated revenue jumped to Rs 4,284.65 lakhs (from Rs 1,644.30 lakhs), PAT grew to Rs 1,481.41 lakhs. Auditor flagged Emphasis of Matter on ECL provision of Rs 502.18 lakhs standalone and Rs 1,110.49 lakhs consolidated. MD Rupesh Savla re-appointed for 5 years.
Strong consolidated growth but auditor flagged ECL provisions on receivables. Standalone PAT dipped. MD continuity is a positive.